Prevacid and Pulmonary function test decreased - a phase IV clinical study of FDA data

Summary:

Pulmonary function test decreased is reported as a side effect among people who take Prevacid (lansoprazole), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Pulmozyme, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Pulmonary function test decreased when taking Prevacid. It is created by eHealthMe based on reports of 128,835 people who have side effects when taking Prevacid from the FDA, and is updated regularly.

What is Prevacid?

Prevacid has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 130,714 Prevacid users. Check the latest studies of Prevacid.

What is Pulmonary function test decreased?

Pulmonary function test decreased is found to be associated with 469 drugs and 497 conditions by eHealthMe. Check the latest studies of Pulmonary function test decreased.

On Jul, 18, 2026

128,835 people reported to have side effects when taking Prevacid.
Among them, 69 people (0.05%) have Pulmonary function test decreased.

Could Prevacid cause Pulmonary function test decreased?

Among these 69 people:

How long have people been on Prevacid when they have Pulmonary function test decreased? *

What is the gender of people who have Pulmonary function test decreased when taking Prevacid? *

female: 64.71 %
male: 35.29 %

What is the age of people who have Pulmonary function test decreased when taking Prevacid? *

What are other drugs people take besides Prevacid? *

What are other side effects people have besides Pulmonary function test decreased? *

Weight Decreased: 29 people, 42.03%
Pain: 25 people, 36.23%
Dyspnea (difficult or laboured breathing): 24 people, 34.78%
Joint Pain: 22 people, 31.88%
Indigestion: 21 people, 30.43%
Urinary Tract Infection: 21 people, 30.43%
Dyspnea Exertional: 21 people, 30.43%
Depression: 20 people, 28.99%
Dizziness: 20 people, 28.99%
Adrenal Neoplasm (abnormal growth of adrenal gland): 19 people, 27.54%

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 36 people, 52.17%
Multiple Myeloma (cancer of the plasma cells): 12 people, 17.39%
Light Chain Analysis Increased: 12 people, 17.39%
Neoplasm Malignant (cancer tumour): 7 people, 10.14%
Lung Disorder (lung disease): 6 people, 8.70%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 5 people, 7.25%
Cough: 5 people, 7.25%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 5 people, 7.25%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 4.35%
Dysmenorrhea (painful menstruation): 3 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Prevacid and have Pulmonary function test decreased?

- Check whether Pulmonary function test decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prevacid:

Prevacid (130,714 reports)

Browse all side effects of Prevacid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary function test decreased:

Pulmonary function test decreased (469 drugs)

Browse all the conditions that are associated with Pulmonary function test decreased:

Pulmonary function test decreased (497 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lansoprazole (the active ingredients of Prevacid) and Prevacid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.